The invention relates generally to derivatives of human C3 protein containing a number of single amino acid changes in the α- and β-chains of C3, designed to increase the affinity of the modified protein to factor B, to lessen the affinity of the modified protein for factor H, and to reduce the immunogenicity of the modified protein as compared to unmodified protein. The invention also presents methods of using these modified proteins for the treatment of certain cancers.